TBCIX
Price
$161.35
Change
-$0.70 (-0.43%)
Updated
Apr 17 closing price
Net Assets
53.33B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

TBCIX vs VIGRX

Header iconTBCIX vs VIGRX Comparison
Open Charts TBCIX vs VIGRXBanner chart's image
T. Rowe Price Blue Chip Growth I
Price$161.35
Change-$0.70 (-0.43%)
VolumeN/A
Net Assets53.33B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
TBCIX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TBCIX vs. VIGRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TBCIX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. TBCIX (53.3B). VIGRX pays higher dividends than TBCIX: VIGRX (0.39) vs TBCIX (0.00). TBCIX was incepted earlier than VIGRX: TBCIX (9 years) vs VIGRX (32 years). TBCIX (0.58) is less costly to investors than VIGRX (0.17). TBCIX is a more actively managed with annual turnover of: 15.70 vs. VIGRX (5.00). VIGRX has a lower initial minimum investment than TBCIX: VIGRX (3000) vs TBCIX (500000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. TBCIX (-2.43). VIGRX return over 5 years is better than : 99.21 vs. TBCIX (33.65).
TBCIXVIGRXTBCIX / VIGRX
Total Expense Ratio0.580.17341%
Annual Report Gross Expense Ratio0.580.17341%
Fund Existence9 years32 years-
Gain YTD-13.523-14.32694%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets53.3B261B20%
Annual Yield % from dividends0.000.39-
Returns for 1 year-2.436.01-40%
Returns for 3 years11.3730.3337%
Returns for 5 years33.6599.2134%
Returns for 10 yearsN/A223.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics